Literature DB >> 15579509

Reversal of glomerular lesions involves coordinated restructuring of glomerular microvasculature.

Marcin Adamczak1, Marie-Luise Gross, Kerstin Amann, Eberhard Ritz.   

Abstract

There is increasing evidence from both human and experimental studies that at least partial reversal of glomerulosclerosis can be achieved by glomerular remodeling. This requires substantial changes in glomerular architecture, specifically of glomerular capillaries. It was the purpose of the present study to characterize the stereologic and topologic characteristics of glomerular capillaries when partial reversal of glomerular lesions is achieved by high-dose angiotensin-converting enzyme inhibitor treatment. Sham-operated male Sprague-Dawley rats were compared with subtotally nephrectomized (SNX) rats. The latter were kept untreated for 8 wk and subsequently randomly divided into one group that was continued without treatment and another group that was treated with enalapril (48 mg/kg body wt per d administered in the drinking fluid for 4 wk). Renal morphology was evaluated after 8 or 12 wk, respectively, by stereologic techniques after pressure-controlled perfusion fixation. In SNX rats at 8 and particularly at 12 wk, the glomerulosclerosis index was significantly higher than in sham-operated rats. At 12 wk, it was lower in rats that had been treated for 4 wk with enalapril compared with untreated SNX rats, suggesting partial reversal of glomerular lesions. This was associated with a decrease in mean glomerular volume and mean glomerular tuft volume, a reduced number of capillaries per glomerulus, and reduced total length of capillaries per glomerulus but without any significant change in the length of individual capillaries. The numerical capillary density (Euler number density) as an index of topologic complexity did not change. The total capillary surface area per glomerulus was strikingly increased after subtotal nephrectomy and partially reversed after enalapril. This was accounted for primarily by fewer capillaries without any change in diameter. In parallel, the number of endothelial cells per glomerulus was strikingly increased after subtotal nephrectomy and decreased with enalapril treatment, but endothelial cell volume remained elevated. The study shows harmonious coordinate remodeling of the entire glomerulus during regression of glomerular lesions after subtotal nephrectomy. Proportionate reduction of glomerular volume and capillary number without change of individual capillary length were found. The numerical capillary density of the tuft therefore remained unchanged.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579509     DOI: 10.1097/01.ASN.0000146121.72699.86

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  22 in total

1.  Animal models of regression/progression of kidney disease.

Authors:  Beom Jin Lim; Hai-Chun Yang; Agnes B Fogo
Journal:  Drug Discov Today Dis Models       Date:  2014

Review 2.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

3.  Kidney regeneration in mammals.

Authors:  Hai-Chun Yang; Shao-Jun Liu; Agnes B Fogo
Journal:  Nephron Exp Nephrol       Date:  2014-05-19

4.  Increased capillary branching contributes to angiotensin type 1 receptor blocker (ARB)-induced regression of sclerosis.

Authors:  Benjamin S Scruggs; Yiqin Zuo; Ellen Donnert; Lijun Ma; John F Bertram; Agnes B Fogo
Journal:  Am J Pathol       Date:  2011-03-03       Impact factor: 4.307

5.  Shear stress is normalized in glomerular capillaries following ⅚ nephrectomy.

Authors:  Nicholas Ferrell; Ruben M Sandoval; Aihua Bian; Silvia B Campos-Bilderback; Bruce A Molitoris; William H Fissell
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

6.  Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.

Authors:  Ji Ma; Taiji Matsusaka; Hai-Chun Yang; Jianyong Zhong; Nobuaki Takagi; Agnes B Fogo; Valentina Kon; Iekuni Ichikawa
Journal:  Pediatr Res       Date:  2011-07       Impact factor: 3.756

7.  Inhibition of periostin expression protects against the development of renal inflammation and fibrosis.

Authors:  Mouna Mael-Ainin; Ahmed Abed; Simon J Conway; Jean-Claude Dussaule; Christos Chatziantoniou
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

8.  Role of remission clinics in the longitudinal treatment of CKD.

Authors:  Piero Ruggenenti; Elena Perticucci; Paolo Cravedi; Vincenzo Gambara; Marco Costantini; Sanjib Kumar Sharma; Annalisa Perna; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 10.121

9.  What is the significance of CD34 immunostaining in the extraglomerular and intraglomerular mesangium?

Authors:  Cristina Gluhovschi; Gheorghe Gluhovschi; Elena Potencz; Diana Herman; Ligia Petrica; Silvia Velciov; Gheorghe Bozdog; Flaviu Bob; Corina Vernic; Daniel Cioca
Journal:  Virchows Arch       Date:  2008-08-08       Impact factor: 4.064

10.  Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.

Authors:  Sema Akman; Salih Kalay; Bahar Akkaya; Mustafa Koyun; Halide Akbaş; Yunus Emre Baysal; Ayfer Gur Guven
Journal:  Pediatr Nephrol       Date:  2009-02-18       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.